News >

Thriving Therapeutics Transform Relapsed/Refractory Myeloma Paradigm

Caroline Seymour
Published: Thursday, Dec 05, 2019

Sagar Lonial, MD, FACP, professor and chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, chief medical officer, Winship Cancer Institute

Sagar Lonial, MD, FACP

Innovative therapeutic regimens are showing promising activity in patients with multiple myeloma, whether they are for those who experience early relapse, have been heavily pretreated, or have refractory disease, explained Sagar Lonial, MD, FACP.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication